Oxford Nanopore Technologies plc
General ticker "ONTTF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.7B (TTM average)
Oxford Nanopore Technologies plc follows the US Stock Market performance with the rate: 25.5%.
Estimated limits based on current volatility of 4.7%: low 1.57$, high 1.73$
Short-term ONTTF quotes
Long-term ONTTF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | £169.67MM | £183.19MM | £223.86MM |
| Operating Expenses | £338.28MM | £335.52MM | £379.14MM |
| Operating Income | £-168.61MM | £-152.33MM | £-155.27MM |
| Non-Operating Income | £18.84MM | £12.37MM | £15.40MM |
| Interest Expense | £2.21MM | £3.56MM | £2.80MM |
| R&D Expense | £103.84MM | £98.92MM | £97.68MM |
| Income(Loss) | £-149.77MM | £-139.96MM | £-139.88MM |
| Taxes | £0.00MM | £0.00MM | £5.30MM |
| Profit(Loss)* | £-154.51MM | £-146.19MM | £-145.18MM |
| Stockholders Equity | £643.85MM | £586.34MM | £463.22MM |
| Inventory | £101.55MM | £99.45MM | £81.49MM |
| Assets | £777.06MM | £742.05MM | £622.40MM |
| Operating Cash Flow | £-137.30MM | £-109.89MM | £-62.79MM |
| Capital expenditure | £27.29MM | £48.64MM | £3.50MM |
| Investing Cash Flow | £-61.79MM | £15.03MM | £48.49MM |
| Financing Cash Flow | £64.73MM | £73.58MM | £-2.10MM |
| Earnings Per Share** | £-0.19 | £-0.16 | £-0.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.